Press Releases

Year

25 Mar '19

Allscripts FollowMyHealth helping drive digital transformation with patient/consumer engagement platform; Expands relationship with Ephraim McDowell Health

CHICAGO , March 25, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) FollowMyHealth® today announced partnership with Ephraim McDowell Health on its enterprise and mobile patient engagement platform. “Innovative providers across the United States are realizing that FollowMyHealth offers the most

PDF Version

19 Mar '19

Pulse8 joins the Health Plan Alliance Group Purchasing Organization with its ground-breaking Formul8™ solution for managing Pharmacy Costs

NASHVILLE, March 19, 2019 (GLOBE NEWSWIRE) -- Pulse8, part of Veradigm™, an Allscripts (NASDAQ: MDRX) business unit, the first – and ONLY one with a patent pending – healthcare analytics and technology company delivering complete visibility into the efficacy of Risk Adjustment, Quality Management,

PDF Version

18 Mar '19

Pulse8 extends the Utility and Technology of its powerful analytic engine, Illumin8 Active Intelligence™ platform

NASHVILLE, March 18, 2019 (GLOBE NEWSWIRE) -- Pulse8, part of Veradigm™, an Allscripts (NASDAQ: MDRX) business unit, the first – and ONLY one with a patent pending – healthcare analytics and technology company delivering complete visibility into the efficacy of Risk Adjustment, Quality Management,

PDF Version

14 Mar '19

Allscripts Partners with Opargo to Drive Improved Patient Care through Optimized Practice Management

A predictive analytics and optimization engine fully integrated with Allscripts Practice Management to improve scheduling capabilities and practice workflows CHICAGO , March 14, 2019 (GLOBE NEWSWIRE) -- Today, Allscripts (NASDAQ:MDRX) announced a strategic partnership with Opargo focused on

PDF Version

13 Mar '19

Veradigm™ Strengthens its Health Plan and Analytics Solutions by Finalizing Partnership with Pulse8

CHICAGO , March 13, 2019 (GLOBE NEWSWIRE) -- Veradigm™, an Allscripts (NASDAQ: MDRX), business unit, announced today that it has strengthened its strategic relationship with Pulse8, a leader in healthcare analytics and technology company. Pulse8 is the first, and only with a patent pending,

PDF Version

11 Mar '19

Alfardan Medical with Northwestern Medicine select Allscripts

Allscripts first client in Qatar to provide first-of-its-kind ambulatory care services CHICAGO , March 11, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) announced today that Alfardan Group , one of the leading family-owned conglomerates in Qatar , and Chicago -based Northwestern Medicine have

PDF Version

06 Mar '19

Arise Austin Medical Center and The Hospital at Westlake Medical Center select Allscripts Sunrise

Texas organizations choose Allscripts Sunrise™ for robust EHR with a single patient record CHICAGO , March 06, 2019 (GLOBE NEWSWIRE) -- Arise Austin Medical Center , located in Austin, TX and The Hospital at Westlake Medical Center , located in West Lake Hills, TX have announced that both

PDF Version

04 Mar '19

Saint Anthony Hospital expands Allscripts partnership to enable clinical data integration between ambulatory and acute settings

Hospital extends and further expands portfolio to provide single clinical and financial record CHICAGO , March 04, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) announced today that Saint Anthony Hospital has signed a Paragon expansion, confirming its commitment to improving the quality of

PDF Version

26 Feb '19

Blessing Health System expands Allscripts partnership with clinical and financial solutions

Health system extends and further expands portfolio to provide integrated platform that includes clinical and financial solutions for both acute and ambulatory settings CHICAGO , Feb. 26, 2019 (GLOBE NEWSWIRE) -- Blessing Health System, a not-for-profit healthcare organization based in Quincy, Ill.

PDF Version

21 Feb '19

Allscripts announces fourth quarter and 2018 full-year results

Record fourth quarter bookings of $531 million up 69% from the prior year period Fourth quarter GAAP diluted EPS of $2.14 ; growth of 11% in non-GAAP diluted EPS to $0.20 Full year 2018 GAAP diluted EPS of $2.04 ; growth of 16% in non-GAAP diluted EPS to $0.72 Closed sale of Netsmart interests on

PDF Version

Pagination

First page
Previous page
…
Page 5
Page 6
Page 7
Page 8
Current page 9
Page 10
Page 11
Page 12
Page 13
…
Next page
Last page

Press Releases

Press Releases

Contact Investor Relations

Request E-mail Alerts